Insulet Corporation Financials

Market Capitalization $19.44 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	47.14
Forward PE	71.63
Price to Sales TTM	$9.80
Price to Book MRQ	$17.39
Enterprise to Revenue	10.07
Enterprise to EBITDA	48.67

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	21.22%
Operating Margin	16.20%
Return on Assets TTM	7.57%
Return on Equity TTM	48.79%

Income Statement

Revenue TTM	$1,983,900,032
Revenue per Share TTM	$28.34
Quarterly Revenue Growth	25.70%
Gross Profit TTM	$1,375,200,000
EBITDA	$415,500,000
Net Income to Common TTM	$420,900,000
Diluted EPS TTM	$5.88
Quarterly Earnings Growth YoY	49.30%

Balance Sheet

Total Cash MRQ	$902,600,000
Total Cash per Share MRQ	$12.87
Total Debt MRQ	$
Total Debt to Equity MRQ	128.91
Current Ratio MRQ	3.68
Book Value per Share MRQ	$15.94

Cash Flow

Operating Cash Flow TTM	$327,800,000
Levered Free Cash Flow TTM	$106,075,000

PODD Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	70,144,800
Float Shares	69,774,411
Avg 10 Volume	552,120
Avg 30 Volume	None
Shares Short	2,695,903
Short Ratio	4.79
Short % of Shares	5.14%
% Held by Insiders	0.33%
% Held by Institutions	104.13%

Stock Price Summary

Beta	1.22
Fifty Two Week Low	$160.19
Fifty Two Week High	$282.86
Fifty Two Week Change	28.89%
Day 50 MA	$267.05
Day 200 MA	$217.84

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date